Established in 1998, Gan & Lee Pharmaceuticals is an advanced biopharmaceutical company specialized in the exploration, formulation, manufacturing, and marketing of insulin and its derivatives, holding a prominent position in the diabetes sector in China. Since its establishment, Gan & Lee has directed its efforts toward insulin synthesis. In 1998, Gan & Lee achieved a significant milestone by creating the initial domestically produced biosynthetic human insulin, a development acknowledged as one of China's top 10 scientific and technological advancements by the Chinese Academy of Sciences and Engineering. Up to now, Gan & Lee has introduced several comparable biosimilar insulin derivative products.
Products & Services
Ganlee Fine (Pen Injection Needle)
GanleePen (reusable insulin pen)
Insulin Aspart
Gan & Lee Pharmaceuticals
Country
People's Republic of ChinaCity
Beijing
Address
No. 8 Nanfeng West 1st Street, Huoxian, Tongzhou District
Insulin Glargine
Gan & Lee Pharmaceuticals
Country
People's Republic of ChinaCity
Beijing
Address
No. 8 Nanfeng West 1st Street, Huoxian, Tongzhou District
Sites
Gan & Lee Pharmaceuticals
Audited
Country
People's Republic of ChinaCity
Beijing
Address
No. 8 Nanfeng West 1st Street, Huoxian, Tongzhou District
Gold
2024 Qualifyze Quality Compliance Rating2024 Qualifyze QCR